Physician profile
Michael Paul Lowe
NPI 1306996798
$777.74
in general payments reported to CMS, 2019-2025
17 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.52 · 2023: $83.37 · 2024: $312 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $148.88 | 2023-2025 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $118.90 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Phathom Pharmaceuticals, INC. | $113.21 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $59.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $43.49 | 2025 | |
| Abbvie INC. | $43.21 | 2023-2025 | |
| Electromed, INC. | $41.63 | 2024-2025 | Smartvest |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.03 | 2025 | Caplyta |
| Pfizer INC. | $32.24 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $21.95 | 2024 | |
| Acadia Pharmaceuticals INC | $20.11 | 2025 | Nuplazid |
| Amarin Pharma, INC. | $19.72 | 2019 | |
| Pelvital USA, INC. | $18.74 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $16.80 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.67 | 2025 | Opsumit, Uptravi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $15.58 | 2024 | Monoferric |
| Abiomed | $13.96 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.